Similar articles

• [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].

  Adam Z, Krejcí M, Pour L, Stepánková S, Cermáková Z, Voska L, Teplan V, Krivanová A, Hájek R, Mayer J. Adam Z, et al. Vnitr Lek. 2009 Nov;55(11):1089-96. Vnitr Lek. 2009. PMID: 20017442 Review. Czech.
• Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma.

  Vera-Llonch M, Oster G, Ford CM, Lu J, Sonis S. Vera-Llonch M, et al. J Support Oncol. 2007 May;5(5):231-5. J Support Oncol. 2007. PMID: 17564153
• High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma.

  Kumar L, Raju GM, Ganessan K, Shawgi S, Menon H, Wadhwa J, Sharma A, Singh R, Kochupillai V. Kumar L, et al. Natl Med J India. 2003 Jan-Feb;16(1):16-21. Natl Med J India. 2003. PMID: 12715951 Clinical Trial.
• Oral melphalan at diagnosis hampers adequate collection of peripheral blood progenitor cells in multiple myeloma.

  Boccadoro M, Palumbo A, Bringhen S, Merletti F, Ciccone G, Richiardi L, Rus C, Bertola A, Giaccone L, Omedè P, Musto P. Boccadoro M, et al. Haematologica. 2002 Aug;87(8):846-50. Haematologica. 2002. PMID: 12161361
• Rationale for adjuvant idiotypic vaccination after high-dose therapy for multiple myeloma.

  Reichardt VL, Okada CY, Stockerl-Goldstein KE, Bogen B, Levy R. Reichardt VL, et al. Biol Blood Marrow Transplant. 1997 Aug;3(3):157-63. Biol Blood Marrow Transplant. 1997. PMID: 9310193 Review.